Gallery
- PM Modi visit USAOnly the mirror in my washroom and phone gallery see the crazy me : Sara KhanKarnataka rain fury: Photos of flooded streets, uprooted treesCannes 2022: Deepika Padukone stuns at the French Riviera in Sabyasachi outfitRanbir Kapoor And Alia Bhatt's Wedding Pics - Sealed With A KissOscars 2022: Every Academy Award WinnerShane Warne (1969-2022): Australian cricket legend's life in picturesPhotos: What Russia's invasion of Ukraine looks like on the groundLata Mangeshkar (1929-2022): A pictorial tribute to the 'Nightingale of India'PM Modi unveils 216-feet tall Statue of Equality in Hyderabad (PHOTOS)
The 18-year-old, Chirag Chikkara clinched a gold medal in the men’s freestyle 57kg categ
- FIFA president Infantino confirms at least 9 African teams for the 2026 World Cup
- Hockey, cricket, wrestling, badminton, squash axed from 2026 CWG in Glasgow
- FIFA : Over 100 female footballers urge FIFA to reconsider partnership with Saudi oil giant
- Ecuador ready to make history against Uruguay: Beccacece
- Divanshi wins second gold as India sweep women's 25m standard pistol at Lima Junior Worlds
WHO to decide on granting Emergency Use Listing to Covaxin next week Last Updated : 06 Oct 2021 12:42:54 AM IST The World Health Organization (WHO) will meet next week with an independent group of experts to take a final decision on whether to grant Emergency Use Listing (EUL) to Covaxin.
The WHO will carry out the risk and benefit assessments next week with the experts and take a final call on granting the much-awaited EUL to Covid vaccine Covaxin.The global health body said, "WHO and an independent group of experts are scheduled to meet next week to carry out the risk/benefit assessments and come to a final decision whether to grant Emergency Use Listing to Covaxin."It added that the EUL process of WHO and the technical advisory group of independent experts is centred on determining if a manufactured vaccine is quality-assured, safe and effective.Indigenous vaccine Covaxin, which has been developed by Bharat Biotech, has not received emergency use approval from the WHO.The Strategic Advisory Group of Expert on Immunization (SAGE) met earlier on Tuesday to decide on Covaxin getting EUL authorisation. However, as no decision could be reached, the global health body will meet again next week to decide on the same.The expert panel started its four-day meet on Monday to decide on policy guidance. The SAGE and the technical advisory group are supposed to go through all the vaccine dossiers submitted to the WHO before deciding on granting EUL to Covaxin."Covaxin manufacturer, Bharat Biotech, has submitting data to the WHO on a rolling basis. It also submitted additional info at WHO's request on 27 September. WHO experts are currently reviewing this information & if it addresses all questions raised, WHO assessment will be finalized next week".The WHO has so far included only six Covid vaccines in its EUL list that includes the Oxford-AstraZeneca vaccine, manufactured as Covishield by the Serum Institute of India.IANS New Delhi For Latest Updates Please-
Join us on
Follow us on
172.31.16.186